This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2018 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
0%
Blinding trachoma
N/A
Intestinal worms
0%
Bilharzia
0%
River blindness
N/A
Zero people received treatment in Madagascar in 2018 20.22 million people did not receive treatment in Madagascar in 2018

Elephantiasis

Treatment coverage remained at 0% in 2017 and 2018.

People needing treatment
19.64m
People receiving treatment
Zero

Blinding trachoma

Madagascar does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 65% in 2017 to 0% in 2018.

Pre-sch and school-aged children needing treatment
6.64m
Pre-school and school-aged children receiving treatment
Zero

Bilharzia

Treatment coverage decreased from 100% in 2017 to 0% in 2018.

School-aged children needing treatment
4.52m
School-aged children receiving treatment
Zero

River blindness

Madagascar does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.